These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1494788)

  • 1. Monoclonal antibodies in human organ transplantation and auto-immune diseases.
    Wijdenes J; Roy C; Morel-Fourrier B; Racadot E
    Therapie; 1992; 47(4):283-7. PubMed ID: 1494788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression with monoclonal antibodies in multiple sclerosis.
    Hafler DA; Weiner HL
    Neurology; 1988 Jul; 38(7 Suppl 2):42-7. PubMed ID: 3260356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of anti-T cell monoclonal antibodies to prevent acute tumor allograft rejection is associated with their inability to deplete or inactivate T cells at the site of rejection.
    Rakhmilevich AL
    Transplantation; 1994 Jul; 58(1):72-80. PubMed ID: 7913562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation tolerance with monoclonal antibodies.
    Wood KJ
    Semin Immunol; 1990 Nov; 2(6):389-99. PubMed ID: 2104277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity.
    Alegre ML; Tso JY; Sattar HA; Smith J; Desalle F; Cole M; Bluestone JA
    J Immunol; 1995 Aug; 155(3):1544-55. PubMed ID: 7636216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
    Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
    J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD3 monoclonal antibody therapy. An approach toward optimization by in vitro analysis of new anti-CD3 antibodies.
    Woodle ES; Thistlethwaite JR; Jolliffe LK; Fucello AJ; Stuart FP; Bluestone JA
    Transplantation; 1991 Aug; 52(2):361-8. PubMed ID: 1714644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interleukin 10 in disseminated lupus erythematosus].
    Emilie D
    J Soc Biol; 2002; 196(1):19-21. PubMed ID: 12134628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic applications of anti-CD4 antibodies.
    Olive D; Mawas C
    Crit Rev Ther Drug Carrier Syst; 1993; 10(1):29-63. PubMed ID: 8472311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helplessness as a strategy for avoiding antiglobulin responses to therapeutic monoclonal antibodies.
    Isaacs JD; Waldmann H
    Ther Immunol; 1994 Dec; 1(6):303-12. PubMed ID: 7584505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porcine humoral immune responses to multiple injections of murine monoclonal antibodies.
    Lohse L; Nielsen J; Kamstrup S; Oleksiewicz MB; Eriksen L
    APMIS; 2005; 113(7-8):489-96. PubMed ID: 16086818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New immunosuppressive therapies in renal transplantation: monoclonal antibodies.
    Buhaescu I; Segall L; Goldsmith D; Covic A
    J Nephrol; 2005; 18(5):529-36. PubMed ID: 16299678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of monoclonal anti-nucleosome auto-antibodies derived from lupus mice.
    Kramers K; Stemmer C; Monestier M; van Bruggen MC; Rijke-Schilder TP; Hylkema MN; Smeenk RJ; Muller S; Berden JH
    J Autoimmun; 1996 Dec; 9(6):723-9. PubMed ID: 9115574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of allograft rejection by anti-T-cell receptor-alpha beta monoclonal antibodies preserving resistance to bacterial infection.
    Eto M; Yoshikai Y; Nishimura Y; Hiromatsu K; Maeda T; Nomoto K; Kong YY; Kubo RT; Kumazawa J; Nomoto K
    Immunology; 1994 Feb; 81(2):198-204. PubMed ID: 8157269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.
    Zeng Y; Gage A; Montag A; Rothlein R; Thistlethwaite JR; Bluestone JA
    Transplantation; 1994 Sep; 58(6):681-9. PubMed ID: 7940687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody treatment of human allograft recipients.
    Delmonico FL; Cosimi AB
    Surg Gynecol Obstet; 1988 Jan; 166(1):89-98. PubMed ID: 3276014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.